These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6478660)

  • 1. Fluorometric study of serum in patients with chronic renal failure.
    Hadjivassiliou AG; Digenis GE; Mayopoulou-Symvoulidis D; Voudiclari S; Tsaparas N; Symvoulidis A
    Clin Nephrol; 1984 Jul; 22(1):39-43. PubMed ID: 6478660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxalic Acid as a uremic toxin.
    Mydlík M; Derzsiová K
    J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of polyamines in patients with chronic renal failure.
    Saito A; Takagi T; Chung TG; Ohta K
    Kidney Int Suppl; 1983 Dec; 16():S234-7. PubMed ID: 6588257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The trace elements zinc and copper in chronic renal failure].
    Prehn B
    Z Urol Nephrol; 1988 Jan; 81(1):35-42. PubMed ID: 3364046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet function in patients on long term peritoneal dialysis.
    Lindsay RM; Friesen M; Koens F; Linton AL; Oreopoulos D; de Veber G
    Clin Nephrol; 1976 Aug; 6(2):335-9. PubMed ID: 954241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hair zinc compared with plasma zinc in uremic patients before and during regular hemodialysis.
    Mountokalakis T; Dakanalis D; Boukis D; Virvidakis K; Voudiklari S; Koutselinis A
    Clin Nephrol; 1979 Nov; 12(5):206-9. PubMed ID: 509794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress in chronic renal failure patients treated by peritoneal dialysis.
    Al-Hashimi AF; Mohammed FH; Al-Khazragi AS
    Saudi Med J; 2004 Sep; 25(9):1186-92. PubMed ID: 15448763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An increase in bile acids in the serum of patients with chronic kidney failure].
    Balestri PL; Berni R; Cupisti A; Giordani R
    Minerva Med; 1995 May; 86(5):207-9. PubMed ID: 7566550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theophylline toxicity risks and chronic renal failure.
    Nicot G; Charmes JP; Lachatre G; Sautereau D; Valette JP; Eichler B; Leroux-Robert C
    Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):398-401. PubMed ID: 2793275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F; Floridi AG; Floridi A; Buoncristiani U
    Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of renal failure on leukotaxis.
    Martin RR; Eknoyan G; Saenz C; Hyde SE; Olivero J
    J Med; 1979; 10(4):267-78. PubMed ID: 294467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastro-duodenal lesions and Helicobacter pylori infection in uremic patients and renal transplant recipients.
    Khedmat H; Ahmadzad-Asl M; Amini M; Lessan-Pezeshki M; Einollahi B; Pourfarziani V; Naseri MH; Davoudi F
    Transplant Proc; 2007 May; 39(4):1003-7. PubMed ID: 17524875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination and serum protein binding of phenylbutazone in patients with renal insufficiency.
    Held H; Enderle C
    Clin Nephrol; 1976 Sep; 6(3):388-93. PubMed ID: 136326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell subset counts and serum immunoglobulin concentrations in patients with chronic renal failure at the Kenyatta National Hospital.
    Gogo KO; McLigeyo SO; Bwayo JJ; Mumo JM
    East Afr Med J; 1998 May; 75(5):271-3. PubMed ID: 9746996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of erythropoiesis in chronic uremic patients treated with intermittent hemodialysis.
    Morra L; Ponassi A; Gurreri G; Moccia F; Caristo G; Mela GS; Sacchetti C
    Biomed Pharmacother; 1987; 41(7):396-9. PubMed ID: 3446291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.